Therapy of disseminated malignant melanoma with recombinant α 2b-interferon and piroxicam: Clinical results with a report of an unusual response-associated feature (Vitiligo) and unusual toxicity (diffuse pulmonary interstitial fibrosis)
- 1 January 1994
- journal article
- clinical trial
- Published by Wiley in Medical and Pediatric Oncology
- Vol. 22 (2) , 103-106
- https://doi.org/10.1002/mpo.2950220208
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Sequential chemoimmunotherapy in the treatment of metastatic melanoma.Journal of Clinical Oncology, 1992
- Role of interferons in the therapy of melanomaMelanoma Research, 1992
- Acute Interstitial Nephritis with the Nephrotic Syndrome Following Recombinant Leukocyte A Interferon Therapy for Mycosis FungoidesNew England Journal of Medicine, 1984
- Vitiligo in patients with metastatic melanoma: A good prognostic signJournal of the American Academy of Dermatology, 1983